Surgery, neuroinflammation and cognitive impairment

EBioMedicine. 2018 Nov:37:547-556. doi: 10.1016/j.ebiom.2018.10.021. Epub 2018 Oct 19.

Abstract

Trauma experienced during surgery can contribute to the development of a systemic inflammatory response that can cause multi-organ dysfunction or even failure. Post-surgical neuroinflammation is a documented phenomenon that results in synaptic impairment, neuronal dysfunction and death, and impaired neurogenesis. Various pro-inflammatory cytokines, such as TNFα, maintain a state of chronic neuroinflammation, manifesting as post-operative cognitive dysfunction and post-operative delirium. Furthermore, elderly patients with post-operative cognitive dysfunction or delirium are three times more likely to experience permanent cognitive impairment or dementia. We conducted a narrative review, considering evidence extracted from various databases including Pubmed, MEDLINE and EMBASE, as well as journals and book reference lists. We found that further pre-clinical and well-powered clinical studies are required to delineate the precise pathogenesis of post-operative delirium and cognitive dysfunction. Despite the burden of post-operative neurological sequelae, clinical studies investigating therapeutic agents, such as dexmedetomidine, ibuprofen and statins, have yielded conflicting results. In addition, evidence supporting novel therapeutic avenues, such as nicotinic and HMGB-1 targeting and remote ischaemic pre-conditioning, is limited and necessitates further investigation.

Keywords: Inflammation; Multiple organ dysfunction syndrome; Neuroinflammation; Surgery; Systemic inflammatory response syndrome; Therapeutic targets.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain Injuries, Traumatic* / metabolism
  • Brain Injuries, Traumatic* / pathology
  • Brain Injuries, Traumatic* / surgery
  • Cognitive Dysfunction* / drug therapy
  • Cognitive Dysfunction* / etiology
  • Cognitive Dysfunction* / metabolism
  • Cognitive Dysfunction* / pathology
  • Dementia* / drug therapy
  • Dementia* / etiology
  • Dementia* / metabolism
  • Dementia* / pathology
  • Dexmedetomidine / therapeutic use*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Ibuprofen / therapeutic use*
  • Inflammation* / drug therapy
  • Inflammation* / etiology
  • Inflammation* / metabolism
  • Inflammation* / pathology
  • Postoperative Complications* / drug therapy
  • Postoperative Complications* / metabolism
  • Postoperative Complications* / pathology

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Dexmedetomidine
  • Ibuprofen